For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Scope of the Report:
The classification of animal stem cell therapy includes dogs, horses and others. And the proportion of dogs in 2017 is about 50.42%, and the proportion is in increasing trend from 2013 to 2017.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58.63% in 2017. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15.17% in 2017.
The worldwide market for Animal Stem Cell Therapy is expected to grow at a CAGR of roughly 38.3% over the next five years, will reach 110 million US$ in 2024, from 16 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Animal Stem Cell Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Medivet Biologics LLC
- VETSTEM BIOPHARMA
- U.S. Stem Cell, Inc
- VetCell Therapeutics
- Celavet Inc.
- Magellan Stem Cells
- Kintaro Cells Power
- Animal Stem Care
- Animal Cell Therapies
- Cell Therapy Sciences
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Veterinary Hospitals
- Research Organizations
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal Stem Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Animal Stem Cell Therapy, with price, sales, revenue and global market share of Animal Stem Cell Therapy in 2017 and 2018.
Chapter 3, the Animal Stem Cell Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal Stem Cell Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Animal Stem Cell Therapy market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Animal Stem Cell Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.